CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleRevenue is $545.85M, above the global median of $520.53M
- FinancialsAltman Z-Score 5.74: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.03%
Annual Rate
CNY 0.06Paid unknown
Payout Ratio
37.5%Sustainable
Payback Period
96.1 yr
Last Ex-Dividend
Jul 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.70BCNY847.00M · vs all stocks (USD)
Trailing P/E
34.75xRevenue (TTM)
3.68BCNY545.85M · vs all stocks (USD)
Profit Margin
4.60%Beta
0.7830xvs all stocks
52-Week Change
-34.16%vs all stocks
Forward Annual Dividend Yield
1.03%vs all stocks
Market Capitalization
5.70BCNY847.00M · vs all stocks (USD)
Enterprise Value
3.68BCNY545.90M · vs all stocks (USD)
Trailing P/E
34.75xForward P/E
19.86xPrice to Sales (TTM)
1.54xPrice to Book (MRQ)
1.33xEnterprise to Revenue
1.00xEnterprise to EBITDA
14.57xGross Margin
55.97%Profit Margin
4.60%Operating Margin
2.58%Return on Assets (TTM)
1.53%Return on Equity (TTM)
4.31%Revenue (TTM)
3.68BCNY545.85M · vs all stocks (USD)
Revenue per Share (TTM)
3.48CNYUpdated Aug 20, 2026Quarterly Revenue Growth
2.80%Gross Profit (TTM)
1.97BCNY293.16M · vs all stocks (USD)
EBITDA (TTM)
309.13MCNY45.91M · vs all stocks (USD)
Net Income (TTM)
168.94MCNY25.09M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-37.10%Operating Cash Flow (TTM)
363.94MCNY54.05M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
188.55MCNY28.00M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0600CNYUpdated Aug 20, 2026Forward Annual Dividend Yield
1.03%vs all stocks
Trailing Annual Dividend Rate
0.0570CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.01%vs all stocks
Payout Ratio
37.50%Minority Interest (Equity)
714.95MCNYFY2025 · Dec 31, 2025Revenue
3.65BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.72BCNYFY2025 · Dec 31, 2025Gross Profit
1.93BCNYFY2025 · Dec 31, 2025Operating Income
208.20MCNY30.92M · vs all stocks (USD)
Pre-tax Income
284.88MCNYFY2025 · Dec 31, 2025Income Tax Expense
47.39MCNYFY2025 · Dec 31, 2025Net Income
237.48MCNYFY2025 · Dec 31, 2025EBIT
290.72MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
415.37MCNYFY2025 · Dec 31, 2025Research & Development
161.72MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.24BCNYFY2025 · Dec 31, 2025Other Operating Expenses
38.53MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
46.20MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
5.84MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1800CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.04BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.04BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
237.48MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-49.73MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
287.13MCNYFY2025 · Dec 31, 2025Free Cash Flow
176.79MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.77BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
237.48MCNYFY2025 · Dec 31, 2025Other Non-cash Items
19.83MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-87.79MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
117.60MCNYFY2025 · Dec 31, 2025Capital Expenditures
-110.34MCNYFY2025 · Dec 31, 2025Sale of Investments
62.21MCNYFY2025 · Dec 31, 2025Other Investing Activity
-11.26MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-59.38MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
296.32MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-438.50MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-65.19MCNYFY2025 · Dec 31, 2025Other Financing Charges
-9.46MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-216.83MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.02BSharesUpdated Aug 20, 2026Float Shares
464.77MSharesUpdated Aug 20, 2026% Held by Insiders
57.72%vs all stocks
% Held by Institutions
0.80%vs all stocks
Total Cash (MRQ)
2.87BCNY426.68M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.83CNYUpdated Aug 20, 2026Total Debt (MRQ)
175.80MCNY26.11M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0353xCurrent Ratio (MRQ)
4.61xBook Value per Share (MRQ)
4.20CNYUpdated Aug 20, 2026Total Assets
5.86BCNY870.01M · vs all stocks (USD)
Total Current Assets
3.98BCNYFY2025 · Dec 31, 2025Total Liabilities
910.12MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.87BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
63.99MCNYFY2025 · Dec 31, 2025Total Current Liabilities
846.13MCNYFY2025 · Dec 31, 2025Cash
1.30BCNYFY2025 · Dec 31, 2025Cash Equivalents
1.59BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.90BCNYFY2025 · Dec 31, 2025Accounts Receivable
424.09MCNYFY2025 · Dec 31, 2025Inventory
437.16MCNYFY2025 · Dec 31, 2025Accounts Payable
289.39MCNYFY2025 · Dec 31, 2025Short-term Debt
126.65MCNYFY2025 · Dec 31, 2025Other Current Liabilities
7.30MCNYFY2025 · Dec 31, 2025Long-term Debt
10.29MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.02BCNYFY2025 · Dec 31, 2025Retained Earnings
2.32BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.95BCNY734.84M · vs all stocks (USD)
52-Week Low
4.89CNYUpdated Aug 20, 202652-Week High
8.56CNYUpdated Aug 20, 202652-Week Change
-34.16%vs all stocks
Beta
0.7830xvs all stocks
50-Day MA
5.44CNYUpdated Aug 20, 2026200-Day MA
6.70CNYUpdated Aug 20, 2026Avg 10-Day Volume
7.86MSharesUpdated Aug 20, 2026Avg 30-Day Volume
8.71MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.1600CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.56Profit Margin: 0.05
Financial Health
Altman Z-Score 5.74: safe zoneNotable
Altman Z-Score: 5.74
High earnings qualityNotable
Earnings Quality Score: 1.29
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Revenue is $545.85M, above the global median of $520.53MNotable
Revenue (USD): 545,849,524.9Global Median: 520,528,949.311
Levered free cash flow is $28M, above the global median of $16.24MNotable
Levered free cash flow (USD): 28,002,825.78Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Mahindra Lifespace Developers Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Royal Holdings Co. Ltd.
Tier 1ProductionUnit ReplicationFlowRule
Tian An China Investments Company Limited
Tier 1ProductionUnit ReplicationRiskInterface
Xi'an High Voltage Apparatus Co., Ltd.
Tier 1ProductionUnit ReplicationFlowRule
Wing Tai Holdings Ltd.
Tier 1ProductionUnit ReplicationRiskRule
China Union Holdings Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Citycon Oyj
Tier 1ProductionUnit ReplicationRiskFlow
Suning Universal Co., Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Shenzhen New Nanshan Holding Co., Ltd.
Tier 1ProductionUnit ReplicationRiskFlow
Kura Sushi Inc.
Tier 1ProductionUnit ReplicationRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Hubei Jumpcan Pharmaceutical Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
CIE Automotive India Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Manhattan Associates Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities